527 related articles for article (PubMed ID: 15494896)
21. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
22. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
23. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
26. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
27. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
[TBL] [Abstract][Full Text] [Related]
28. Management of genital herpes in HIV-infected patients.
Aoki FY
Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
Sall RK; Kauffman CL; Levy CS
Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
[TBL] [Abstract][Full Text] [Related]
30. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ
Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus infection in cancer patients: prevention and treatment.
Tang IT; Shepp DH
Oncology (Williston Park); 1992 Jul; 6(7):101-6, 109; discussion 109-10. PubMed ID: 1322152
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
[TBL] [Abstract][Full Text] [Related]
33. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
Strick LB; Wald A; Celum C
Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851
[TBL] [Abstract][Full Text] [Related]
34. Treatment of herpes simplex virus infections.
Gold D; Corey L
Clin Lab Med; 1987 Dec; 7(4):815-29. PubMed ID: 2446818
[TBL] [Abstract][Full Text] [Related]
35. Antiviral agents for herpes simplex virus.
Vere Hodge RA; Field HJ
Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
[TBL] [Abstract][Full Text] [Related]
36. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
Losada I; Cañizares A; Hellín T; Martí-Belda P; Guerrero A
Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):25-7. PubMed ID: 11820977
[TBL] [Abstract][Full Text] [Related]
37. An unusual vulval lesion in an HIV-infected woman.
Boothby M; Radcliffe K
Int J STD AIDS; 2007 Mar; 18(3):218-9. PubMed ID: 17362560
[TBL] [Abstract][Full Text] [Related]
38. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
McGrath BJ; Newman CL
Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
[TBL] [Abstract][Full Text] [Related]
39. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man.
Henao-Martínez AF; Weinberg A; Waldman WJ; Levi ME
J Clin Virol; 2012 Jul; 54(3):276-8. PubMed ID: 22465339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
